Published in Leuk Lymphoma on July 01, 2001
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol (2011) 2.11
Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy. Rheumatol Int (2004) 0.82
A Fatal Case of Acute Myeloid Leukaemia-Methotrexate Related or Primary Autoimmune Disease Related: A Rare Case Report. J Clin Diagn Res (2016) 0.75
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report. Oncol Lett (2017) 0.75
High-speed DNA sequencing: an approach based upon fluorescence detection of single molecules. J Biomol Struct Dyn (1989) 7.94
Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer (1981) 5.89
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst (1998) 3.56
Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A (1968) 2.95
Murine eosinophil granulocytes bind the murine macrophage-monocyte specific monoclonal antibody F4/80. J Leukoc Biol (1991) 2.42
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood (1999) 1.85
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med (1992) 1.76
An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer (1987) 1.72
Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science (1982) 1.66
Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med (1984) 1.59
Rodent peritoneal macrophages as bone resorbing cells. Calcif Tissue Int (1979) 1.59
Contact-mediated bone resorption by human monocytes in vitro. Science (1978) 1.57
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant (2005) 1.56
Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol (1998) 1.55
Peritoneal exudate cells. I. Growth requirement of cells capable of forming colonies in soft agar. J Cell Physiol (1974) 1.54
Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk Res (2001) 1.54
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res (1994) 1.54
Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer (1998) 1.52
Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet (1992) 1.50
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
Stochastic versus deterministic in haemopoiesis: what is what? Br J Haematol (1991) 1.46
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res (1988) 1.45
Multidrug resistance in acute myeloid leukemia. J Natl Cancer Inst (1991) 1.45
A method for counting phytohemagglutinin-stimulated lymphocytes. Blood (1967) 1.45
Colony formation by mouse peritoneal exudate cells in vitro. Nat New Biol (1973) 1.42
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia (2010) 1.41
DNA-dependent RNA polymerase levels during the response of human peripheral lymphocytes to phytohemagglutinin. Cell (1975) 1.39
Effects of prestorage white cell-reduction of apheresis platelets on platelet glycoprotein Ib and von Willebrand factor. Transfusion (1992) 1.39
Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen. Radiology (1992) 1.39
Involvement of 6p in benign lipomas. A new cytogenetic entity? Cancer Genet Cytogenet (1989) 1.39
Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res (1997) 1.38
Proliferation and colony-forming ability of peritoneal exudate cells in liquid culture. J Exp Med (1975) 1.38
Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood (1991) 1.36
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol (1997) 1.36
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol (1999) 1.36
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene (1992) 1.34
The response of human peripheral blood lymphocytes to phytohemagglutinin: determination of cell numbers. Cell Immunol (1975) 1.34
Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986. Cancer (1989) 1.33
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant (2003) 1.32
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol (1995) 1.30
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Clin Cancer Res (1999) 1.29
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res (2007) 1.28
Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry (1991) 1.27
Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine (Baltimore) (1995) 1.22
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol (1985) 1.20
Quantitative RT-PCR for measuring gene expression. Biotechniques (1995) 1.19
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer. J Clin Oncol (2000) 1.17
Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood (1994) 1.12
Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc Natl Acad Sci U S A (1994) 1.12
A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics (1997) 1.12
Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol (1997) 1.11
Macrophage growth factor and its relationship to colony stimulating factor. J Reticuloendothel Soc (1978) 1.11
Human Ia-like antigens in non-lymphoid organs. Immunology (1979) 1.10
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood (1997) 1.10
Intestinal ulceration and malabsorption syndromes. Gastroenterology (1980) 1.09
Surely a natural cancer remedy can't be dangerous. BMJ (1990) 1.08
Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor. Int J Cancer (1978) 1.06
Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells. Proc Natl Acad Sci U S A (1987) 1.05
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene (2012) 1.05
The relationship of race, sex, and age to concentrations of serum immunoglobulins expressed in international units in healthy adults in the USA. Bull World Health Organ (1975) 1.02
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood (1998) 1.02
Replication of lactic dehydrogenase virus and Sindbis virus in mouse peritoneal macrophages. Induction of interferon and phenotypic mixing. Virology (1975) 1.02
Hypercalcemia complicating childhood malignancies: a report of seven cases with some pathophysiological considerations. Cancer (1979) 1.00
Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Res Treat (1996) 1.00
Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus. Arthritis Rheum (1986) 0.99
Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome. Cancer (1985) 0.98
Quantitation of cell concentration using the flow cytometer. Cytometry (1982) 0.97
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry. Leukemia (1998) 0.97
Healing of joint erosions in rheumatoid arthritis. Arthritis Rheum (1990) 0.96
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol (2001) 0.96
Staphylococcal infection of the subacromial/subdeltoid bursa. J Rheumatol (1990) 0.96
Pancreatic carcinoma and palmar fasciitis. Ann Intern Med (1983) 0.96
Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. J Clin Oncol (1984) 0.95
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood (1999) 0.95
Proliferative capacity of mouse peritoneal macrophages in vitro. J Exp Med (1978) 0.95
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia. Leukemia (2013) 0.95
Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Hepatology (1999) 0.94
Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res (1998) 0.94
Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer (1996) 0.94
Automated single-cell manipulation and sorting by light trapping. Appl Opt (1987) 0.93
The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22. Genomics (1991) 0.93
Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. J Neuroimmunol (1995) 0.92
Interaction of macrophages with tumor cells. Adv Exp Med Biol (1976) 0.92